Latest Orphan drug Stories
Report uncovers results and trends unavailable from any other news service and before pharmaceutical company disclosures; webinar speakers include former director of FDA’s Office of Orphan Drugs.
Despite federal incentives for drug companies to create treatments for rare diseases, thousands of people are still searching for lifesaving therapies.
The Rare Disease Panel will present on October 7, 2013 at 9:45 a.m. Bethesda, MD (PRWEB) September 30, 2013 WHAT: Thirty years after the adoption of
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.